Ausgewählte Publikationen von Prof. Dr. O. Ritter

Higazi DR, Fearnley CJ, Drawnel FM, Talasila A, Corps EM, Ritter O, McDonald F, Mikoshiba K, Bootman MD, Roderick HL. Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol Cell. 2009;33(4):472-82. IF 12.9

Nordbeck P, Bauer WR, Fidler F, Warmuth M, Hiller KH, Nahrendorf M, Maxfield M, Wurtz S, Geistert S, Broscheit J, Jakob PM, and Ritter O. Feasibility of Real Time Magnetic Resonance Imaging with a Novel Carbon Catheter for Interventional Electrophysiology. Circulation: Arrhythmia and Electrophysiology2009;2:258–267

Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, Hofmann U, Bonz A, Frantz S, Cartwright EJ, Neyses L, Maier LS, Maier SK, Renne T, Schuh K, Ritter O.Conditional nNOS overexpression impairs myocardial contractility. Circ Res 2007: 100(3):e32-44. IF 9.8

Hallhuber M, Burkard N, Wu R, Buch MH, Engelhardt S, Hein L, Neyses L, Schuh K, Ritter O. Inhibition of Nuclear Import of Calcineurin Prevents Myocardial Hypertrophy. Circ Res. 2006:15;99(6):626-35. IF 9.8

Wu RX, Laser M, Han H, Varadarajulu J, Schuh K, Hallhuber M, Hu K, Ertl G, Hauck CR, Ritter O.
SPARC expression after myocardial infarction orchestrates fibroblast migration and tissue remodelling.
J Mol Med 2006; 84:241-52

Ritter O, Koller ML, Fey B, Seidel B, Krein A, Langenfeld H, Bauer WR.
Progression of heart failure in right univentricular pacing compared to biventricular pacing.
Int J Cardiol. 2006;110:359-65

Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O. Targeted Proteolysis Sustains Calcineurin Activation. Circulation 2005;111:1045-53 IF 10.94

Nahrendorf M, Spindler M, Hu K, Bauer L, Ritter O, Nordbeck P, Quaschning T, Hiller KH, Wallis J, Ertl G, Bauer WR, Neubauer S.
Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction.
Cardiovasc Res. 2005;65:419-27

Brede M; Roell W; Ritter O; Wiesmann F; Jahns R; Haase A; Fleischmann B; Hein L:
Angiotensin AT2 Receptors Prevent Cardiac Hypertrophy after Myocardial Infarction.
Hypertension 2003,42:1177-82

Ritter O, Neyses L.
The molecular basis of heart failure.
Trends in Molecular Medicine; 2003;9:313-21

Ritter O, Schuh K, Brede M, Röthlein N, Burkard N, Hein L, Neyses L.
AT2-receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway.
FASEB J. 2003; 17, 283-285

Ritter O, Hack S, Schuh K, Rothlein N, Perrot A, Osterziel KJ, Schulte HD, and Neyses L.
Calcineurin in human heart hypertrophy.
Circulation 2002; 105, 2265-2269